Home
Scientific CommunicationsMedia
Autoantibodies against myeloperoxidase (MPO), proteinase 3 (PR3), and glomerular basement membrane (GBM) are critical diagnostic markers for ANCA-associated vasculitides, microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), eosinophilic GPA (EGPA), and anti-GBM disease.
Accurate and timely detection of anti-neutrophil cytoplasmic antibodies (ANCA)—specifically against myeloperoxidase (MPO)and proteinase 3 (PR3).
Extended serological profiling may improve autoimmuneconnective tissue diseases (CTD) diagnosis.
This study assesses the analytical performance of a novel automated immunoassay microarray for autoantibodies associated with Celiac Disease. Presented at ACG 2024.
This study assesses the performance characteristics of a novel automated immunoassay microarray for detecting Anti-Centromere Protein B (CENP-B) antibodies. Presented at AACC 2023.
This study assesses the performance characteristics of a novel automated immunoassay microarray for detecting Anti-Centromere Protein B (CENP-B) antibodies.
This study assesses the performance characteristics of a novel automated immunoassay microarray for detecting 11 IgG antibodies associated with Connective Tissue Diseases. Presented at ACR 2023.
This study assesses the analytical performance of a novel automated immunoassay microarray for detecting 15 IgG antibodies associated with Connective Tissue Diseases. Presented at IFCC2024.
This study assesses the analytical performance of a novel automated immunoassay microarray for detecting 11 antibodies associated with Connective Tissue Diseases, in a Spanish Reference Laboratory. Presented at ADLM2024.
This study assesses a fully automated immunoassay microarray for detecting Bet v 1-specific IgE, offering improved accuracy and efficiency in allergy diagnostics. Presented at ECI 2024.